Our Services
Medical Information
Helpful Resources
Published on: 5/22/2026
Eosinophilic rhinosinusitis is a subtype of chronic sinus inflammation characterized by persistent, thick, eosinophil-rich nasal discharge and congestion that often fails to improve with antibiotics alone. Tailored management includes topical corticosteroids, saline irrigation and biologic therapies that target interleukin pathways, guided by drainage color, consistency, volume and laboratory confirmation of eosinophils.
There are several factors to consider; see below for a complete discussion of diagnostic criteria, immunologic drivers and practical next steps.
Eosinophilic rhinosinusitis (EoRS) is a subtype of chronic rhinosinusitis characterized by a high number of eosinophils—special white blood cells—in the nasal and sinus tissues. This form of sinus inflammation often leads to persistent, thick nasal discharge and congestion, significantly affecting quality of life. By understanding the mechanisms that drive EoRS and the criteria for identifying thick drainage, patients and clinicians can work together to tailor effective treatment plans.
EoRS is defined by:
Unlike acute sinusitis—usually triggered by a virus or bacteria—EoRS reflects an underlying immune dysfunction. In many cases, patients also have asthma or other allergic conditions, although EoRS can occur without obvious allergies.
Eosinophils are part of the body's defense against parasites and play a role in allergic reactions. In EoRS:
Understanding this process helps explain why classic sinus treatments (like antibiotics alone) often fail to resolve symptoms in EoRS patients.
Proper identification of "thick" drainage is essential for diagnosis and management. The eosinophilic rhinosinusitis thick drainage criteria commonly include:
While color alone isn't a definitive sign of bacterial infection, in EoRS it reflects the accumulation of eosinophils and cellular debris. If you consistently notice these features, discuss them with your healthcare provider.
Diagnosing EoRS involves a combination of clinical evaluation and specialized tests:
History and Physical Exam
Laboratory Studies
Imaging
Collectively, these findings help confirm EoRS and guide personalized treatment strategies.
EoRS is driven by complex immunologic pathways. Key molecules include:
Biologic therapies targeting these pathways (e.g., anti-IL-5 monoclonal antibodies) have transformed management for patients with severe or refractory disease. Early identification of thick, eosinophil-rich drainage can help clinicians select the right biologic agent.
Management of EoRS focuses on reducing inflammation, clearing thick mucus, and restoring normal sinus function. Common approaches include:
• Topical nasal corticosteroids (e.g., fluticasone, budesonide)
• Short courses of systemic corticosteroids for acute flares
• Saline irrigations with isotonic or hypertonic solutions to loosen thick drainage
• Biologic agents (e.g., mepolizumab, benralizumab) in patients with high eosinophil counts
• Endoscopic sinus surgery to remove polyps, open sinus ostia, and improve drug delivery
Patients often require a combination of these treatments, adjusted over time based on response and side effects.
Living with thick nasal discharge can be challenging. Consider these strategies:
These measures, alongside medical treatments, can significantly improve comfort and sinus clearance.
If you experience any of the following, contact your healthcare provider promptly:
These signs may indicate complications or an alternative diagnosis requiring urgent attention.
If you're experiencing persistent nasal congestion, thick drainage, or facial pressure and want to better understand your symptoms, try Ubie's free AI-powered Sinusitis symptom checker. This quick assessment can help you determine whether your symptoms align with various forms of sinus inflammation and provide guidance on next steps. Always share the results with your doctor for a thorough evaluation.
While this overview provides a detailed look at EoRS and the eosinophilic rhinosinusitis thick drainage criteria, it's not a substitute for professional medical advice. If you experience persistent or severe symptoms, speak to your doctor—especially if you have any life-threatening or serious concerns. Early diagnosis and tailored therapy can greatly improve outcomes and quality of life.
(References)
* Fokkens WJ, Schlemmer M, van Bruaene N, Gevaert P, Pugin B, Rinia AB, Van Zele T, Bachert C. Eosinophilic Chronic Rhinosinusitis: An Update. Laryngoscope Investig Otolaryngol. 2021 Dec 21;7(1):153-162. doi: 10.1002/lio2.730. PMID: 34977464; PMCID: PMC8710323.
* Bachert C, Han JK, Van Zele T, Gevaert P. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2021 Sep;9(9):3226-3236. doi: 10.1016/j.jaip.2021.06.009. Epub 2021 Jun 26. PMID: 34217688.
* Lam K, Gengler I, Leventon G, Kern RC. Type 2 Inflammation in Chronic Rhinosinusitis with Nasal Polyps: Pathophysiology, Biologics, and Future Perspectives. J Asthma Allergy. 2023 Jul 21;16:511-523. doi: 10.2147/JAA.S419747. PMID: 37485304; PMCID: PMC10370008.
* Katial RK, Krouse JH. Mechanisms of disease: Eosinophilic chronic rhinosinusitis and allergic fungal rhinosinusitis. J Allergy Clin Immunol. 2022 Jan;149(1):1-10. doi: 10.1016/j.jaci.2021.08.016. Epub 2021 Sep 1. PMID: 34487661.
* Kim JW, Nam W, Cha HE, Kim DW. Mucin composition and rheological properties of nasal mucus in chronic rhinosinusitis with nasal polyps. Sci Rep. 2022 Feb 15;12(1):2572. doi: 10.1038/s41598-022-06497-6. PMID: 35165239; PMCID: PMC8846399.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.